Expert stakeholder perspectives on the acceptability of treatment-as-prevention in prison: a qualitative substudy of the 'Surveillance and Treatment of Prisoners with Hepatitis C' project (SToP-C).

作者： Jake Rance , Lise Lafferty , Carla Treloar , SToP‐C Study Group

关键词: Prison 、 Stakeholder 、 Prioritization 、 Hepatitis C 、 Treatment as prevention 、 Sekhon 、 Harm reduction 、 Family medicine 、 Interview data 、 Psychology

摘要: BACKGROUND AND AIMS Mathematical modelling has demonstrated the theoretical feasibility of HCV treatment-as-prevention strategies in custodial settings, yet limited empirical data exists. The Australian 'Surveillance and Treatment Prisoners with Hepatitis C' study is world's first trial hepatitis C virus (HCV) prison. This aimed to analyse how expert stakeholders involved response assessed acceptability prison using interview from SToP-C qualitative substudy. DESIGN SETTING Qualitative analysis semi-structured interviews Australia. PARTICIPANTS Nineteen key experts. MEASUREMENTS Drawing upon Sekhon's framework acceptability, were organized thematically under four component constructs acceptability: affective attitude; ethicality; opportunity costs; perceived effectiveness. FINDINGS Most differences participant assessments a matter relative emphasis prioritization rather than absolute polarity. Nonetheless, small minority participants was overtly critical approach. Arguing against focus on treatment, they instead advocated for prevention-as-prevention, including improvement expansion existing harm reduction measures. CONCLUSIONS stakeholder prisons found no opposition universal rollout direct-acting anti-virals, but most voiced concern regarding lack effective primary prevention prisons.

参考文章(38)

Lucy Platt, Silvia Minozzi, Jennifer Reed, Peter Vickerman, Holly Hagan, Clare French, Ashly Jordan, Louisa Degenhardt, Vivian Hope, Sharon Hutchinson, Lisa Maher, Norah Palmateer, Avril Taylor, Julie Bruneau, Matthew Hickman, None, Needle and syringe programmes and opioid substitution therapy for preventing HCV transmission among people who inject drugs: findings from a Cochrane Review and meta-analysis. Addiction. ,vol. 113, pp. 545- 563 ,(2018) , 10.1111/ADD.14012

Sofia R Bartlett, Penny Fox, Harris Cabatingan, Anissa Jaros, Carla Gorton, Rhondda Lewis, Eugene Priscott, Gregory J Dore, Darren B Russell, None, Demonstration of Near-Elimination of Hepatitis C Virus Among a Prison Population: The Lotus Glen Correctional Centre Hepatitis C Treatment Project. Clinical Infectious Diseases. ,vol. 67, pp. 460- 463 ,(2018) , 10.1093/CID/CIY210

Jeffrey V Lazarus, Kelly Safreed-Harmon, Kristina L Hetherington, Daniel J Bromberg, Denise Ocampo, Niels Graf, Anna Dichtl, Heino Stöver, Hans Wolff, Health Outcomes for Clients of Needle and Syringe Programs in Prisons. Epidemiologic Reviews. ,vol. 40, pp. 96- 104 ,(2018) , 10.1093/EPIREV/MXX019

Gregory J. Dore, Behzad Hajarizadeh, Elimination of Hepatitis C Virus in Australia: Laying the Foundation. Infectious Disease Clinics of North America. ,vol. 32, pp. 269- 279 ,(2018) , 10.1016/J.IDC.2018.02.006

Kelly Safreed-Harmon, Mark Thursz, John Dillon, Manal El-Sayed, Ahmed Elsharkawy, Angelos Hatzakis, Michel Jadoul, Tullio Prestileo, Homie Razavi, Jürgen Rockstroh, Stefan Wiktor, Massimo Colombo, Jeffrey Lazarus, The Micro-Elimination Approach to Eliminating Hepatitis C: Strategic and Operational Considerations Seminars in Liver Disease. ,vol. 38, pp. 181- 192 ,(2018) , 10.1055/S-0038-1666841

Lise Lafferty, Jake Rance, Jason Grebely, Andrew R. Lloyd, Gregory J. Dore, Carla Treloar, , Understanding facilitators and barriers of direct‐acting antiviral therapy for hepatitis C virus infection in prison Journal of Viral Hepatitis. ,vol. 25, pp. 1526- 1532 ,(2018) , 10.1111/JVH.12987

Timothy Papaluca, Alexander Thompson, HCV elimination: breaking down the barriers to prison based care Hepatoma Research. ,vol. 4, pp. 64- ,(2018) , 10.20517/2394-5079.2018.53

Christy Newman, Shana Hughes, Asha Persson, Hong-Ha M. Truong, Martin Holt, Promoting ‘Equitable Access’ to PrEP in Australia: Taking Account of Stakeholder Perspectives Aids and Behavior. ,vol. 23, pp. 1846- 1857 ,(2019) , 10.1007/S10461-018-2311-2

Graham S Cooke, Isabelle Andrieux-Meyer, Tanya L Applegate, Rifat Atun, Jessica R Burry, Hugo Cheinquer, Geoff Dusheiko, Jordan J Feld, Charles Gore, Max G Griswold, Saeed Hamid, Margaret E Hellard, JinLin Hou, Jess Howell, Jidong Jia, Natalia Kravchenko, Jeffrey V Lazarus, Maud Lemoine, Olufunmilayo A Lesi, Liudmyla Maistat, Brian J McMahon, Homie Razavi, Teri Roberts, Bryony Simmons, Mark W Sonderup, C Wendy Spearman, Bridie E Taylor, David L Thomas, Imam Waked, John W Ward, Stefan Z Wiktor, Ayman Abdo, Rakesh Aggarwal, Alessio Aghemo, Bandar Al-Judaibi, Mamun Al Mahtab, Arshad Altaf, Zyaad Ameen, Tarik Asselah, Oidov Baatarkkhuu, Ella Barber, Eleanor Barnes, Pascale Boulet, Louise Burrows, Maia Butsashvili, Erica Chan, Chelsea Chow, Ben Cowie, Chris Cunningham, Alexandre de Araujo, Graciela Diap, Greg Dore, Joseph Doyle, Manal Elsayed, Emmanuel Fajardo, Ed Gane, Aneley Getahun, David Goldberg, Tiffany Got, Matthew Hickman, Andrew Hill, Sharon Hutchinson, Chris Jones, Saleem Kamili, Amreen Khan, Alice Lee, Tin Yan Lee, Jioiji Malani, Tammy Meyers Morris, Shevanthi Nayagam, Richard Njouom, Ponsiano Ocama, Alisa Pedrana, Rosanna Peeling, Amulya Reddy, Jilian Sacks, Shiv Sarin, Yusuke Shimakawa, Marcela Silva, Pavlo Skala, Simon Taylor-Robinson, Alex Thompson, Mark Thursz, Alfred Tonganibeia, Jack Wallace, James Ward, Fernando Wolff, Peter Vickerman, Johnny Yau, None, Accelerating the elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission The Lancet Gastroenterology & Hepatology. ,vol. 4, pp. 135- 184 ,(2019) , 10.1016/S2468-1253(18)30270-X

10.

Martin Holt, Christy E. Newman, Kari Lancaster, Anthony K. Smith, Shana Hughes, Hong‐Ha M. Truong, HIV pre-exposure prophylaxis and the 'problems' of reduced condom use and sexually transmitted infections in Australia: a critical analysis from an evidence-making intervention perspective. Sociology of Health and Illness. ,vol. 41, pp. 1535- 1548 ,(2019) , 10.1111/1467-9566.12967

Expert stakeholder perspectives on the acceptability of treatment-as-prevention in prison: a qualitative substudy of the 'Surveillance and Treatment of Prisoners with Hepatitis C' project (SToP-C).

来源期刊

我的账户

Expert stakeholder perspectives on the acceptability of treatment-as-prevention in prison: a qualitative substudy of the 'Surveillance and Treatment of Prisoners with Hepatitis C' project (SToP-C).

来源期刊

相似文章 1

Considering treatment-as-prevention scale-up for Australian prisons: a qualitative sub-study of expert stakeholders from the Australian 'surveillance and treatment of prisoners with hepatitis C' project (SToP-C).

我的账户